Modern Solutions in the Treatment of HIV: From Antiretroviral Drug Therapy to Human Genome Editing
Milana Ruslanovna Sebaeva, Iman Vladimirovna Gelogaeva, Naida Ramizovna Suleymanova, Kamila Umarovna Balaeva, Aishat Arslanovna Dauletova, Zuhra Magomedovna Zakoroeva, Saida Hanbertovna Kasheshova, Takis Albertovich Kozmov, Madina Muslimovna Minatulaeva, Alina Yuryevna Maslova
Journal of Pharmaceutical Research International · pp. 159–169 · Published 16 Nov 2021
10.9734/jpri/2021/v33i50A33392Abstract
The human immunodeficiency virus (HIV) belongs to a group of anthroponotic viral diseases that cause HIV infection in the human body, apotheosely transforming into acquired immunodeficiency syndrome (AIDS). HIV infection, in people without adequate treatment, can lead to serious damage to the immune system (hereinafter referred to as IS), which leads to a sharp decrease in resistance to conditionally pathogenic microbes, as well as to the prevalence of oncological pathologies that may lead to death. Due to its simplicity, convenience, efficiency and cost-effectiveness, CRISPR/Cas has found application in a short period of time in a wide variety of fields of fundamental and applied medicine and biotechnology.
Cited by 0
No indexed citations yet.
Related research
- Advancing Exclusive Breastfeeding among HIV-Positive Mothers in Low Resource Settings — shares topic coverage
- Seroprevalence of HIV, HBV and HCV among Prisoners in Sokoto, Nigeria — shares topic coverage
- Knowledge, Attitude and Utilization of HIV Post-Exposure Prophylaxis among Health Care Workers at HIV Treatment Centers in Port-Harcourt Metropolis — shares topic coverage
- Outcome of Prevention of Mother to Child Transmission (PMTCT) of HIV Services at the University of Port Harcourt Teaching Hospital (UPTH), Port Harcourt, Nigeria — shares topic coverage
- Pattern of Otorhinolaryngological Disorders in HIV Positive Paediatric Patients at the University of Port Harcourt Teaching Hospital (UPTH) — shares topic coverage
Article metrics
Real usage data collected on this platform.
20
Page views
0
PDF downloads
9
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.